Geode Capital Management LLC Has $37.74 Million Stock Position in Acadia Healthcare Company, Inc. $ACHC

Geode Capital Management LLC cut its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 1.1% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,663,167 shares of the company’s stock after selling 19,208 shares during the period. Geode Capital Management LLC owned 1.81% of Acadia Healthcare worth $37,744,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Hawk Ridge Capital Management LP grew its holdings in Acadia Healthcare by 437.5% during the first quarter. Hawk Ridge Capital Management LP now owns 2,473,226 shares of the company’s stock valued at $74,988,000 after purchasing an additional 2,013,126 shares during the period. Citigroup Inc. boosted its position in Acadia Healthcare by 5,144.2% during the 1st quarter. Citigroup Inc. now owns 2,376,209 shares of the company’s stock worth $72,047,000 after acquiring an additional 2,330,898 shares during the last quarter. Maverick Capital Ltd. increased its stake in Acadia Healthcare by 116.3% in the 1st quarter. Maverick Capital Ltd. now owns 2,246,923 shares of the company’s stock valued at $68,127,000 after buying an additional 1,208,296 shares during the last quarter. Abrams Bison Investments LLC acquired a new stake in shares of Acadia Healthcare in the first quarter valued at about $55,182,000. Finally, Khrom Capital Management LLC raised its stake in shares of Acadia Healthcare by 26.9% during the 1st quarter. Khrom Capital Management LLC now owns 1,587,299 shares of the company’s stock worth $48,127,000 after purchasing an additional 336,297 shares in the last quarter.

Acadia Healthcare Stock Performance

Shares of ACHC opened at $17.15 on Thursday. The firm’s fifty day simple moving average is $21.67 and its two-hundred day simple moving average is $22.17. Acadia Healthcare Company, Inc. has a 12 month low of $14.30 and a 12 month high of $47.08. The stock has a market capitalization of $1.58 billion, a P/E ratio of 11.36, a price-to-earnings-growth ratio of 4.56 and a beta of 0.97. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.01. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The firm had revenue of $851.57 million for the quarter, compared to analyst estimates of $852.43 million. During the same period in the previous year, the firm earned $0.91 earnings per share. The company’s revenue was up 4.4% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. As a group, analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Analysts Set New Price Targets

Several brokerages recently issued reports on ACHC. Cowen reiterated a “buy” rating on shares of Acadia Healthcare in a research note on Thursday, August 7th. Royal Bank Of Canada dropped their price objective on shares of Acadia Healthcare from $28.00 to $22.00 and set an “outperform” rating for the company in a research note on Wednesday, November 12th. Mizuho cut their target price on Acadia Healthcare from $32.00 to $22.00 and set a “neutral” rating for the company in a research report on Wednesday, August 13th. Cantor Fitzgerald reduced their price target on shares of Acadia Healthcare from $25.00 to $22.00 and set a “neutral” rating on the stock in a research report on Friday, November 7th. Finally, UBS Group lowered their target price on Acadia Healthcare from $31.00 to $28.00 and set a “buy” rating for the company in a research note on Friday, November 7th. Eight analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $32.36.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.